Appropriate Use of Blood Cultures in the Emergency Department Through Machine Learning
Condition(s) studied
Investigational drug(s) / intervention(s)
Blood culture prediction tool: Machine learning based predicition tool
Study summary
The goal of this clinical trial is to study whether the use of our blood culture prediction tool is non-inferior to current practice and if it can improve certain outcomes in all adult patients presenting to the emergency department with a clinical indication for a blood culture analysis (according to the treating physician). The primary endpoint is 30-day mortality. Key secondary outcomes are:
* hospital admission rates
* in-hospital mortality
* hospital length-of-stay. In the intervention group, the physician will follow the advice of our blood culture prediction tool.
In the comparison group all patients will undergo a blood culture analysis.
Eligibility
Primary outcome measure(s)
- 30-day mortality — 30 days
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Amsterdam UMC - location AMC | Amsterdam | Netherlands | Recruiting |
More Amsterdam UMC, location VUmc trials in the Netherlands
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06163781 on ClinicalTrials.gov ↗ ← All trials in the Netherlands